Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical agent for treatment of withdrawal symptoms

Pharmaceutical agent for treatment of withdrawal symptoms

US Patent 5385903 · Granted Jan 31, 1995

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs2010
Non-invasive drug self-administration system for animals2009
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N2008
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N2008
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N2008
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N2007
Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors fo2007
Quinoxaline-carboxylic acid derivatives2001
Quinoxaline-carboxylic acid derivatives2001
Use of quisqualate receptor antagonists2001
Use of quisqualate receptor antagonists2001
Quinoxalinedione derivatives, their production and use in pharmaceutical agents2000